Sands Capital Life Sciences Pulse Fund II, L.P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$3M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sands Capital Life Sciences Pulse Fund II, L.P.

According to the SEC Form 4 filings, Sands Capital Life Sciences Pulse Fund II, L.P., being in a position of

  1. 10 percent owner at Inhibikase Therapeutics, Inc.,
    оver the last 12 months, has bought 2068965 shares for $3M, and sold 0 shares,
    over all time since 2025-11-21, has bought 2068965 shares for $3M, and sold 0 shares.

Biography of Sands Capital Life Sciences Pulse Fund II, L.P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $2,999,9991100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-11-21PurchaseInhibikase Therapeutics, Inc.
IKT
10 percent owner
2.07M
2.6795%
$1.45$3M+23.49%
Total: 1
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.